Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:30 PM ET Form 4
Insider Buying Four Corners Property Trust, Inc. FCPT

Four Corners Property Trust President and CEO William H. Lenehan Buys $150K of Stock

William H. Lenehan, President and CEO, bought 6,468 shares of Four Corners Property Trust, Inc. at $23.19 a share, worth $150K in total on Nov 13, 2026. Shares held after the trade: 796,325 (+0.8%).

Value
$150K
Shares
6,468
Price
$23.19
Role
President and CEO
Holding change
+0.8%
Trade date
Nov 13, 2026
4:30 PM ET Form 4
Insider Selling Genius Sports Ltd GENI

Genius Sports Chief Commercial Officer Jack Davison Sells $184K of Stock

Jack Davison, Chief Commercial Officer, sold 30,000 shares of Genius Sports Ltd at $6.14 a share, worth $184K in total on Nov 12, 2026. Shares held after the trade: 1,999,706 (-1.5%).

Value
$184K
Shares
30,000
Price
$6.14
Role
Chief Commercial Officer
Holding change
-1.5%
Trade date
Nov 12, 2026
4:30 PM ET 10-Q
Financial Results Evernorth Holdings Inc. XRPN

Evernorth Holdings Q3 2026 Results: Turns Profitable, Net Income $155M

Evernorth Holdings Inc. reported its third-quarter 2026 financial results, highlighting continued growth in its pharmacy benefit management and specialty pharmacy segments. The filing indicates a focus on expanding specialty pharmacy capabilities and managing medical cost trends effectively while maintaining stable full-year guidance.

Key figure
Net income $155M
4:30 PM ET 8-K
Stock Buyback Boston Omaha Corp BOC

Boston Omaha Announces $85M Stock Buyback

Boston Omaha Corporation's Board of Directors has voted to significantly increase its share repurchase program from $30 million to $85 million. The program allows for repurchases of Class A common stock through open market or private transactions and is set to expire on December 31, 2027. The company intends to fund the buybacks using available cash and cash equivalents.

Value
$85M
Term
through Dec 2027
4:30 PM ET 10-Q
Financial Results Egain Corp EGAN

Egain Q1 2026 Results: Net Income $1.55M, Down 45.0% YoY

For the quarter ended September 30, 2026, eGain reported total revenue of $21.9 million, a decrease from $23.5 million in the prior year, primarily driven by lower SaaS and professional services revenue. Net income declined to $1.55 million ($0.06 per diluted share) compared to $2.82 million ($0.10 per diluted share) in the same period last year. The company continued its share repurchase program, spending $3.6 million to buy back 644,000 shares during the quarter.

Key figure
Net income $1.55M · -45.0% YoY
4:30 PM ET 8-K/A
Financial Results NIQ Global Intelligence plc NIQ

NIQ Global Intelligence Financial Results

NIQ Global Intelligence reported Q3 2026 financial results, achieving positive GAAP EPS for the first time since its IPO with net income of $35.8 million. The company exceeded guidance across all key metrics, raised its full-year 2026 outlook, and announced a new $150 million share repurchase authorization after reaching its net leverage target ahead of schedule.

“Q3 was a milestone quarter — we exceeded the top end of our guidance across all key metrics for the sixth consecutive quarter, delivered positive GAAP earnings per share for the first time since our IPO, and reached our net leverage milestone a quarter ahead of plan.”

Jim Peck, Executive Chairman and Chief Executive Officer
4:30 PM ET 10-Q
Financial Results Core University Living Real Estate Income Trust

Core University Living Real Estate Income Trust Q3 2026 Results: Net Loss of $2.03M

Core University Living Real Estate Income Trust commenced operations in July 2026, acquiring an initial portfolio of four student housing properties for approximately $300.5 million. For the period from formation through September 30, 2026, the company reported a net loss of $2.8 million on rental revenues of $6.3 million, primarily due to depreciation, interest expense, and general and administrative costs.

Key figure
Net loss $2.03M
4:28 PM ET 8-K
Reverse Stock Split PharmaCyte Biotech, Inc. PMCB

PharmaCyte Biotech Reverse Stock Split

PharmaCyte Biotech implemented a 1-for-19 reverse stock split of its common stock effective November 12, 2026. The split consolidated approximately 10.8 million outstanding shares into roughly 0.57 million shares to increase the per-share trading price. The action is intended to help the company regain compliance with the Nasdaq minimum bid price requirement for continued listing.

4:28 PM ET 10-Q
Financial Results Hashdex Nasdaq CME Crypto Index ETF NCIQ

Hashdex Nasdaq CME Crypto Index ETF Q3 2026 Results: Net Income $125M, Up 661.9% YoY

As of September 30, 2026, the Hashdex Nasdaq CME Crypto Index ETF reported net assets of $498.3 million, a significant increase from $121.3 million at the end of 2025. The Trust's portfolio is heavily weighted in Bitcoin (73.79%) and Ethereum (11.98%), and it recently transitioned its reference index to the Nasdaq CME Crypto Settlement Price Index in January 2026.

Key figure
Net income $125M · +661.9% YoY
4:28 PM ET Form 4
Insider Selling Icu Medical Inc ICUI

Icu Medical Insider Elisha W. Finney Sells $316K of Stock

Elisha W. Finney sold 1,765 shares of Icu Medical Inc at $179.00 a share, worth $316K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 4,871 (-25.9%).

Value
$316K
Shares
1,765
Average price
$179.00
Holding change
-25.9%
Trade date
Nov 12, 2026 to Nov 13, 2026
4:28 PM ET Form 4
Insider Selling Arxis, Inc. ARXS

Arxis Insider Ross Bradley Sealfon Sells $783K of Stock

Ross Bradley Sealfon sold 15,000 shares of Arxis, Inc. at $51.44 to $53.03 a share (average $52.23) in 3 transactions, worth $783K in total on Nov 11, 2026. Shares held after the trade: 1,087,807 (-0.4%).

Value
$783K
Shares
15,000
Average price
$52.23
Holding change
-0.4%
Trade date
Nov 11, 2026
4:28 PM ET Form 4
Insider Buying Altimmune, Inc. ALT

Altimmune CFO Gregory L. Weaver Buys $16.2K of Stock

Gregory L. Weaver, CFO, bought 10,000 shares of Altimmune, Inc. at $1.62 a share, worth $16.2K in total on Nov 13, 2026. Shares held after the trade: 73,005 (+15.9%).

Value
$16.2K
Shares
10,000
Price
$1.62
Role
CFO
Holding change
+15.9%
Trade date
Nov 13, 2026
4:27 PM ET Form 4
Insider Selling Cavco Industries, Inc. CVCO

Cavco Industries President,Manufactured Housing Brian R. Cira Sells $1.59M of Stock

Brian R. Cira, President,Manufactured Housing, sold 2,382 shares of Cavco Industries, Inc. at $666.91 a share, worth $1.59M in total on Nov 10, 2026. Shares held after the trade: 1,908 (-55.5%).

Value
$1.59M
Shares
2,382
Price
$666.91
Role
President,Manufactured Housing
Holding change
-55.5%
Trade date
Nov 10, 2026
4:27 PM ET Form 4
Insider Buying Altimmune, Inc. ALT

Altimmune Director Wayne Pisano Buys $16.4K of Stock

Wayne Pisano, Director, bought 10,000 shares of Altimmune, Inc. at $1.64 a share, worth $16.4K in total on Nov 13, 2026. Shares held after the trade: 58,800 (+20.5%).

Value
$16.4K
Shares
10,000
Price
$1.64
Role
Director
Holding change
+20.5%
Trade date
Nov 13, 2026
4:27 PM ET Form 4
Insider Buying Aldeyra Therapeutics, Inc. ALDX

Aldeyra Therapeutics Director Richard Douglas Buys $129K of Stock

Richard Douglas, Director, bought 200,000 shares of Aldeyra Therapeutics, Inc. at $0.6445 a share, worth $129K in total on Nov 11, 2026. Shares held after the trade: 395,000 (+102.6%).

Value
$129K
Shares
200,000
Price
$0.6445
Role
Director
Holding change
+102.6%
Trade date
Nov 11, 2026
4:27 PM ET 8-K
Dividend Cinemark Holdings, Inc. CNK

Cinemark Holdings Dividend

Cinemark Holdings, Inc. declared a quarterly cash dividend of $0.09 per share of common stock. The dividend is scheduled to be paid on December 9, 2026, to stockholders of record as of November 25, 2026.

4:27 PM ET 8-K
Business Update Ares Industrial Real Estate Income Trust Inc.

Ares Industrial Real Estate Income Trust Business Update

Ares Industrial Real Estate Income Trust reported its monthly Net Asset Value (NAV) as of October 31, 2026, with an Aggregate Fund NAV of approximately $5.31 billion. The transaction price for December 1, 2026, will be based on this updated NAV per share calculation. The filing also details the company's total investment portfolio of $10.36 billion, which includes industrial properties, joint ventures, and real estate debt.

4:27 PM ET Form 4
Insider Buying Altimmune, Inc. ALT

Altimmune President and CEO Jerome Benedict Durso Buys $49.7K of Stock

Jerome Benedict Durso, President and CEO, bought 30,700 shares of Altimmune, Inc. at $1.62 a share, worth $49.7K in total on Nov 13, 2026. Shares held after the trade: 93,200 (+49.1%).

Value
$49.7K
Shares
30,700
Price
$1.62
Role
President and CEO
Holding change
+49.1%
Trade date
Nov 13, 2026
4:26 PM ET 10-Q
Financial Results Vine Hill Capital Investment Corp. II VHCP

Vine Hill Capital Investment Corp. II Q3 2026 Results: Turns Profitable, Net Income $1.71M

Vine Hill Capital Investment Corp. II reported net income of $4.97 million for the nine months ended September 30, 2026, primarily driven by $6.25 million in interest income from its Trust Account. As a shell company, it continues to seek an initial business combination while maintaining $236.5 million in Class A ordinary shares subject to possible redemption.

Key figure
Net income $1.71M
4:26 PM ET Form 4
Insider Selling Eplus Inc PLUS

Eplus COO Darren S. Raiguel Sells $419K of Stock

Darren S. Raiguel, COO, sold 4,268 shares of Eplus Inc at $98.12 to $99.26 a share (average $98.26) in 3 transactions, worth $419K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 60,768 (-0.5%).

Value
$419K
Shares
4,268
Average price
$98.26
Role
COO
Holding change
-0.5%
Trade date
Nov 11, 2026 to Nov 12, 2026
4:26 PM ET 8-K
Loan & Debt Enbridge Inc ENB

Enbridge $1.1B Debt Financing with Deutsche Bank Trust Company Americas

Enbridge Inc. completed a dual-tranche debt offering totaling $1.1 billion in aggregate principal amount. The offering consisted of $550 million in 6.700% Series A Fixed-to-Fixed Rate Subordinated Notes and $550 million in 6.875% Series B Fixed-to-Fixed Rate Subordinated Notes, both due in 2057.

Value
$1.1B
Counterparty
Deutsche Bank Trust Company Americas
Term
through 2057
4:26 PM ET 8-K
Business Update Ares Real Estate Income Trust Inc. ZARE

Ares Real Estate Income Trust Business Update

Ares Real Estate Income Trust Inc. reported its monthly Net Asset Value (NAV) update for October 31, 2026, showing an Aggregate Fund NAV of approximately $3.95 billion. The company's total real estate investment portfolio was valued at $9.30 billion, with industrial and residential properties representing the largest asset classes. The transaction price for share classes starting December 1, 2026, will be based on these October 31 NAV calculations.

4:26 PM ET 10-Q
Financial Results FiEE, Inc. FIEE

FiEE Q3 2026 Results: Turns Profitable, Net Income $1.12M

FiEE, Inc. reported a significant turnaround for the nine months ended September 30, 2026, achieving net income of $3.58 million compared to a net loss of $1.27 million in the prior year period. This growth was driven by a substantial increase in revenues to $9.57 million, up from $1.98 million, alongside the acquisition of new subsidiaries.

Key figure
Net income $1.12M
4:26 PM ET 8-K/A
Financial Results Suncrete, Inc. RMIX

Suncrete Financial Results

Suncrete, Inc. filed an amendment to its Q3 2026 earnings report to correct errors in its full-year 2026 outlook caused by a technical disruption. The company updated its projected net loss to a range of $43.7M to $39.7M and its adjusted net loss to $16.8M to $12.8M, while maintaining its previously issued revenue and Adjusted EBITDA guidance.

Term
Q3 2026
4:26 PM ET 8-K
Leadership Change Kontoor Brands, Inc. KTB

Kontoor Brands Leadership Change

Kontoor Brands announced that Jennifer H. Broyles will transition to the role of Executive Vice President, Global Brand President, Wrangler. This title change is effective upon the closing of the company's previously announced sale of its Lee business. Ms. Broyles will continue to serve as an executive officer of the company.

4:25 PM ET Form 4
Insider Selling Genpact LTD G

Genpact SVP and CHRO Piyush Mehta Sells $8.61M of Stock

Piyush Mehta, SVP and CHRO, sold 200,000 shares of Genpact LTD at $43.05 a share, worth $8.61M in total on Nov 10, 2026. Shares held after the trade: 156,823 (-56.1%).

Value
$8.61M
Shares
200,000
Price
$43.05
Role
SVP and CHRO
Holding change
-56.1%
Trade date
Nov 10, 2026
4:25 PM ET 8-K
Other 8-K Filing Goldman Sachs Group Inc GS

Goldman Sachs Group Other 8-K Filing

Goldman Sachs filed Certificates of Elimination to its Restated Certificate of Incorporation to remove all designations related to its Series O and Series V Preferred Stock. This administrative action follows the full redemption of all outstanding shares of both series on November 10, 2026.

4:25 PM ET 10-Q
Financial Results Next Bridge Hydrocarbons, Inc.

Next Bridge Hydrocarbons Q3 2026 Results: Net Loss of $1.77M, Loss Narrows

Next Bridge Hydrocarbons, Inc. reported 288,458,813 shares of common stock outstanding as of November 13, 2026. The filing indicates the company is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, with financial statements covering the quarter ended September 30, 2026.

Key figure
Net loss $1.77M
4:24 PM ET 8-K
Financial Results Annovis Bio, Inc. ANVS

Annovis Bio Financial Results

Annovis Bio reported third quarter 2026 financial results and provided a clinical update on its Phase 3 DUET-AD study for Alzheimer's disease, with a data readout expected in March 2027. The company also highlighted a $21.0 million capital raise from an underwritten public offering intended to fund operations through the upcoming clinical milestones.

Term
Q3 2026

“The third quarter marked a shift in our focus from enrolling patients in DUET-AD to executing the trial and preparing for the first data readout and for filing a New Drug Application (NDA). We now have dates set for last patient, last visit of the 6-month treatment period and for database lock, as well as financing in place to carry us through topline results in March 2027. The team is working very hard to deliver clean data and an on-time readout.”

Maria Maccecchini, PhD, President and CEO of Annovis
4:24 PM ET 8-K
Business Update Invesco Commercial Real Estate Finance Trust, Inc. INCREF

Invesco Commercial Real Estate Finance Trust Business Update

Invesco Commercial Real Estate Finance Trust, Inc. reported its monthly Net Asset Value (NAV) as of October 31, 2026, totaling approximately $1.5 billion. The NAV per share across its various share classes ranged from $24.87 to $26.27, which will serve as the transaction price for December 1, 2026. The company's portfolio is primarily composed of $6.99 billion in commercial real estate loan investments offset by $5.74 billion in financing liabilities.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.